Aurealis Therapeutics attended the 33rd European Society of Gene & Cell Therapy (ESGCT) Annual Congress, held in collaboration with the German Society of Gene Therapy (DG-GT) from 27 to 30 October 2026 at the Congress Center Hamburg. CTO Hanna Lesch and COO Laurent Décory represented the company.
The congress brought together researchers, clinicians and industry professionals to share the latest research and advances in gene and cell therapy. Hanna also attended as Chair of the ESGCT Manufacturing Committee.